Piedmont Investment Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-36,840
Closed -$6.08M 345
2020
Q1
$6.08M Sell
36,840
-20,649
-36% -$3.78M 0.24% 97
2019
Q4
$11.3M Buy
57,489
+1,521
+3% +$285K 0.39% 65
2019
Q3
$10.1M Buy
55,968
+25,653
+85% +$4.44M 0.39% 65
2019
Q2
$5.3M Buy
30,315
+54
+0.2% +$9.25K 0.21% 116
2019
Q1
$5.75M Sell
30,261
-13,059
-30% -$2.32M 0.23% 109
2018
Q4
$6.92M Sell
43,320
-2,817
-6% -$477K 0.33% 79
2018
Q3
$8.83M Buy
46,137
+12,768
+38% +$2.27M 0.37% 67
2018
Q2
$5.32M Sell
33,369
-21,933
-40% -$3.34M 0.26% 91
2018
Q1
$7.61M Sell
55,302
-21,651
-28% -$3.02M 0.2% 127
2017
Q4
$9.36M Buy
76,953
+732
+1% +$91.6K 0.19% 144
2017
Q3
$8.86M Buy
76,221
+567
+0.7% +$61.8K 0.19% 141
2017
Q2
$7.86M Buy
75,654
+69,318
+1,094% +$6.66M 0.17% 155
2017
Q1
$540K Sell
6,336
-54
-0.8% -$4.27K 0.01% 355
2016
Q4
$450K Buy
6,390
+981
+18% +$72.1K 0.01% 335
2016
Q3
$436K Buy
5,409
+5,400
+60,000% +$413K 0.01% 327
2016
Q2
$661 Buy
+9
New +$633 ﹤0.01% 400

Other funds holding ISRG

Piedmont Investment Advisors's ISRG Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Intuitive Surgical (ISRG) in Q2 2020, closing a stake of 36,840 shares — an estimated $6.08M sold.

Piedmont Investment Advisors first reported a position in ISRG in Q2 2016 and held it in 16 quarters. The position peaked at $11.3M in Q4 2019. 1,048 funds tracked by Wall St. Rank hold ISRG as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Intuitive Surgical position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 36,840 Intuitive Surgical shares in Q2 2020, an estimated $6.08M.
  • Piedmont Investment Advisors first reported a position in Intuitive Surgical in Q2 2016 and held it in 16 quarters.
  • Piedmont Investment Advisors's Intuitive Surgical position peaked at $11.3M in Q4 2019.
  • 1,048 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.